Capital Social e Reservas Alterar Data
AbbVie USD -5.94B 721M 2026-06
Amgen USD 11.69B 2.5B 2026-06
AstraZeneca USD 50.3B 2.96B 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Canopy Growth CAD 697.59M 60.58M 2026-03
Corcept Therapeutics USD 705.78M 67.79M 2026-06
Drreddys Laboratories INR 380.46B 376.31B 2026-03
Eli Lilly USD 31.2B 4.66B 2026-03
Genmab DKK 5.85B 96M 2025-12
GlaxoSmithKline GBP 17.64B 223M 2026-06
Glaxosmithkline GBP 17.42B 4.64B 2026-03
J&J USD 84.97B 3.78B 2026-06
Lakefront Biotherapeutics EUR 3.25B 17.5M 2026-03
Merck USD 45.88B 6.73B 2026-03
Novartis USD 41.95B 3.02B 2026-06
Novartis USD 38.93B 7.2B 2026-03
Pacira USD 671.98M 18.08M 2026-06
Perrigo USD 2.5B 436.7M 2026-03
Pfizer USD 85.19B 4.91B 2026-06
Phibro Animal Health USD 361.83M 29.47M 2026-03
Prestige Brands USD 1.89B 58.06M 2026-03
Roche Holding CHF 32.69B 1.11B 2026-06
Sanofi EUR 69.57B 3.24B 2026-06
Sanofi EUR 73.14B 1.43B 2026-03
Supernus Pharmaceuticals USD 1.03B 45.58M 2026-06
UCB EUR 10.87B 1.18B 2025-12
Zoetis USD 3.23B 98M 2026-03